WallStSmart
COCP

Cocrystal Pharma Inc

NASDAQ: COCP · HEALTHCARE · BIOTECHNOLOGY

$1.39
+0.00% today

Updated 2026-04-29

Market cap
$19.71M
P/E ratio
P/S ratio
92.45x
EPS (TTM)
$-0.78
Dividend yield
52W range
$1 – $2
Volume
3.0M

WallStSmart proprietary scores

24
out of 100
Grade: F
Strong Sell
Investment rating
5.7
Growth
C+
5.0
Quality
C+
3.0
Profitability
D
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target
$8.00
+475.54%
12-Month target
Intrinsic (DCF)
$5.32
Margin of safety
+82.06%
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 26.90% QoQ
+ 82.06% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.74M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$510000.00
Net income$-38.84M$-17.98M$-17.50M$-8.83M$-2.43M
EPS$-0.78
Free cash flow$-21.51M$-14.78M$-16.49M$-8.20M$-1.74M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
COCP$19.71M245.73.06.75.0+82.06%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Cocrystal Pharma Inc trades at $1.39. Our Smart Value Score of 24/100 indicates the stock is weak. TTM revenue stands at $510000.00. Our DCF model estimates intrinsic value at $5.32.

Frequently asked questions

What is Cocrystal Pharma Inc's stock price?
Cocrystal Pharma Inc (COCP) trades at $1.39.
Is Cocrystal Pharma Inc overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell). DCF value $5.32.
What is the price target of Cocrystal Pharma Inc (COCP)?
The analyst target price is $8.00, representing +475.5% upside from the current price of $1.39.
What is the intrinsic value of Cocrystal Pharma Inc (COCP)?
Based on our DCF model, intrinsic value is $5.32, a +82.1% margin of safety versus $1.39.
What is Cocrystal Pharma Inc's revenue?
TTM revenue is $510000.00.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio92.45x
ROE-111.40%
Beta1.18
50D MA$1.17
200D MA$1.22
Shares out0.01B
Float0.01B
Short ratio
Avg volume3.0M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years